-
Janney: Time To Buy Acceleron
Monday, February 29, 2016 - 1:52pm | 315Read More...On Monday, Janney issued a company note on Acceleron Pharma Inc (NASDAQ: XLRN) after the company announced positive Phase III trial results of their drug that treats metastatic renal cell carcinoma (mRCC). Analysts at Janney upgraded Acceleron from Neutral to Buy, while lowering their price target...
-
SunEdison Responds Following Hawaiian Electric Contract Cancellation
Friday, February 19, 2016 - 11:34am | 609Read More...According to a report by Bloomberg, Sunedison Inc (NYSE: SUNE) fell "so far behind" on some of its solar farms that its client Hawaiin Electric Co. (HECO) canceled its contract for 148 megawatts of solar power. Shares of SunEdison were trading unchanged at $1.51 after Friday's opening bell. HECO...
-
Janney Starts Antero Midstream At Buy; Long-Term Outlook Called 'Superior' Amid Drilling Panic
Tuesday, February 9, 2016 - 4:00pm | 354Read More...Janney analysts Nathan Judge and Akil Marsh initiated coverage of Antero Midstream Partners LP (NYSE: AM) with a Buy rating and a $27.00 fair value estimate on Monday. According to the report, the firm believes the pullback in the stock opens an attractive entry point for long long-term investors...
-
Carl Icahn's AIG Analysis Makes One Giant Assumption
Wednesday, December 2, 2015 - 11:01am | 383Read More...American International Group Inc (NYSE: AIG) shares are up 14.48 percent year-to-date, almost touching their 52 week high on December 1. Janney’s Larry Greenberg has maintained a Neutral rating on the company. Greenberg disagreed with Carl Icahn’s initial letter to AIG’s...
-
Janney Downgrades American States Water To Sell
Friday, October 16, 2015 - 11:18am | 241Read More...American States Water Co (NYSE: AWR) shares have been volatile in 2015 and are up 8 percent year-to-date. Janney’s Michael Gaugler downgraded the rating on the company from Neutral to Sell, while maintaining the fair value estimate at $36. Investors should book profits in view of...
-
Janney Trims SunEdison Estimates: Here's Why
Thursday, October 8, 2015 - 9:31am | 257Read More...The share price of Sunedison Inc (NYSE: SUNE) has declined 67.86 percent over the past three months, touching a low of $6.66 on September 29. Janney’s Michael Gaugler has maintained a Buy rating on the company, while lowering the price target from $23 to $20. SunEdison...
-
Raptor Pharmaceuticals Buys Quinsair: What You Need To Know
Friday, August 21, 2015 - 9:34am | 455Read More...Raptor Pharmaceutical Corp. (NASDAQ: RPTP), a biopharmaceutical company with a focus on developing and commercializing transformative treatments for people affected by rare and debilitating diseases, announced Thursday evening that it has entered into a definitive agreement with Tripex...
-
Calls Of Note: Shake Shack, Kate Spade And Other Notable Research Notes Worth Following On Tuesday
Tuesday, August 11, 2015 - 10:53am | 1107Read More...The following represents a hand-picked selection of notable research curated by an analyst known in some circles as "The Sith Overlord Of The Street." Longbow: Shake Shack Trends ‘Picking Up,' Maintains At Neutral Alton Stump of Longbow Research maintained a Neutral rating on shares of Shake Shack...
-
Analyst Sees Success For Tonix Pharmaceuticals Holdings Corp.
Thursday, May 7, 2015 - 4:43pm | 262Read More...Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) lead drug candidate for fibromyalgia and post-traumatic stress disorder shows promise despite flunking a recent Phase IIb trial, an analyst said. Tonix, up about 5 percent in the past three months, changed hands recently at $6.06, up $0.06 cents....
-
What 8 Top Analysts Are Saying About Urban Outfitters
Tuesday, March 10, 2015 - 6:00pm | 1194Read More...Urban Outfitters, Inc. (NASDAQ: URBN) reported Q4 earnings Monday and beat expectations. The stock surged following the earnings release and closed at $44.06 on Tuesday, up 11.52 percent. Numerous analysts commented on the stock, including Credit Suisse and FBR. Many analysts were positive on...
-
Janney Expects Weather To Hurt McDonald's February Sales
Wednesday, March 4, 2015 - 4:41pm | 170Read More...Janney commented on February sales for McDonald's Corporation (NYSE: MCD) Wednesday and maintained a Neutral rating with an $89 price target. Analyst Mark Kalinowski suspected that U.S. comp sales for McDonald's slowed during February as sales in the chain burger sector deteriorated...
-
Janney Names Chain Restaurants To Watch In 2015
Wednesday, January 7, 2015 - 5:11pm | 370Read More...Analyst Mark Kalinowski of Janney has his eye on chain restaurants in 2015, specifically Domino's Pizza, Inc. (NYSE: DPZ) and Starbucks Corporation (NASDAQ: SBUX). With high levels of consumer confidence and low gas prices, consumers have a larger disposable income and are more likely to...
-
Athletic Footwear Sees Declines In Sales
Wednesday, November 5, 2014 - 12:03pm | 175Read More...Athletic footwear stocks may come under pressure as Janney cited adverse SportScan data, according to Bloomberg. According to the report, athletic footwear sales fell in week ended November 1 by 6.5 percent year-over-year. This compares to a 20.6 percent increase in the previous year. The...
-
UPDATE: Janney Capital Upgrades Gap On Improving Business Model
Friday, August 22, 2014 - 12:50pm | 110Read More...Following an upbeat earnings report, Janney Capital upgraded shares ofThe Gap (NYSE: GPS) from Neutral to Buy on Friday. Adrienne Tennant stated five reasons for the upgrade: General sector strength, as Janney analysts expect softlines sector inventory to reduce. This may imply improving...
-
Janney Sends McDonald's Down With Sales Estimate
Wednesday, July 16, 2014 - 9:06am | 121Read More...Shares of McDonald’s (NYSE: MCD) gapped lower Wednesday morning after Janney cut estimates on weak domestic sales. According to a survey conducted by Janney, franchisees’ sales outlook is the weakest it has been in a decade. This was enough for the research house to cut its June...
